[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613809":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":29,"responsibleParty":45,"collaborators":11,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":11,"eligibilityCriteria":54,"healthyVolunteers":51,"sex":55,"minAge":56,"maxAge":11,"enrollmentInfo":57,"targetDuration":11,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":32,"whyStopped":11,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Thiazides treatment arm","ACTIVE_COMPARATOR",null,[13],"Drug: Hydrochlorothiazide 25mg once per day",{"label":15,"type":16,"description":11,"interventionNames":11},"Control arm","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"DRUG","Hydrochlorothiazide 25mg once per day","Thiazides diuretics",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Gordon Chan, MD, MRCP","CONTACT","0085235052211","cck295@ha.org.hk",[30],{"facility":31,"status":32,"city":33,"state":11,"zip":11,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Prince of Wales Hospital. The Chinese University of Hong Kong","RECRUITING","Hong Kong","HK",{"type":36,"coordinates":37},"Point",[38,39],114.17469,22.27832,{"lat":39,"lon":38},[42],{"name":43,"role":26,"phone":27,"phoneExt":11,"email":44},"CC Szeto, MD, FRCP","ccszeto@cuhk.edu.hk",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Chan Chun Kau Gordon","Dr","100613809","phase-4-blood-pressure-control-with-thiazide-diuretics-in-peritoneal-dialysis-patients-100613809",false,"NCT07271420","Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients","Inclusion Criteria:\n\n* Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \\>140 mmHg and\u002For DBP \\>90 mmHg)\n\nExclusion Criteria:\n\n* Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months","ALL","18 Years",{"count":58,"type":59},40,"ESTIMATED","INTERVENTIONAL",[62],"PHASE4","To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis",[65,66,67],"Hypertension","Peritoneal Dialysis","End Stage Kidney Disease (ESRD)",[65,21,69,70],"End stage kidney disease","Peritoneal dialysis","2025-11-26",{"date":73,"type":74},"2025-12-09","ACTUAL",{"date":76,"type":74},"2020-01-01",{"date":78,"type":59},"2027-06-30",{"name":5,"class":6},1]